APO Research
Talk to an analyst

APO RESEARCH · REPORT

Marine Biopharmaceutical

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Marine Biopharmaceutical Market Analysis and Forecast 2026-2032

19 December 2025194 pages

Choose your research edition.

Industry ResearchMarine Biopharmaceutical Industry Research Report 2026128 pages · $2,950 USDIndustry Growth & TrendsGlobal Marine Biopharmaceutical Industry Growth and Trends Forecast to 2032111 pages · $3,450 USDMarket StructureGlobal Marine Biopharmaceutical Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Marine Biopharmaceutical Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Marine Biopharmaceutical Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Marine Biopharmaceutical market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Marine Biopharmaceutical is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Marine Biopharmaceutical is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Marine Biopharmaceutical is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Marine Biopharmaceutical is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Marine Biopharmaceutical include Takeda, Pfizer, GSK, TerSera Therapeutics, Seattle Genetics, Pharma Mar SA, Pelagia (EPAX), Nordic Naturals and GNC, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Marine Biopharmaceutical, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Marine Biopharmaceutical, also provides the revenue of main regions and countries. Of the upcoming market potential for Marine Biopharmaceutical, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Marine Biopharmaceutical revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Marine Biopharmaceutical market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Marine Biopharmaceutical revenue, projected growth trends, production technology, application and end-user industry.

Marine Biopharmaceutical Segment by Company

Takeda

Pfizer

GSK

TerSera Therapeutics

Seattle Genetics

Pharma Mar SA

Pelagia (EPAX)

Nordic Naturals

GNC

Eisai Co

DSM

Croda

Carlson Labs

BASF

Amway

Marine Biopharmaceutical Segment by Type

Drugs

Health Supplement

Marine Biopharmaceutical Segment by Application

Hospital & Clinic

Pharmacy

Other

Marine Biopharmaceutical Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Marine Biopharmaceutical market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Marine Biopharmaceutical and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Marine Biopharmaceutical.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Marine Biopharmaceutical in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Marine Biopharmaceutical company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Marine Biopharmaceutical revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Marine Biopharmaceutical Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Drugs Major Player Table 3. Health Supplement Major Player Table 4. Global Marine Biopharmaceutical Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Hospital & Clinic Major Player Table 6. Pharmacy Major Player Table 7. Other Major Player Table 8. Marine Biopharmaceutical Industry Trends Table 9. Marine Biopharmaceutical Industry Drivers Table 10. Marine Biopharmaceutical Industry Opportunities and Challenges Table 11. Marine Biopharmaceutical Industry Restraints Table 12. Global Marine Biopharmaceutical Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 13. Global Marine Biopharmaceutical Market Size by Region (2021-2026) & (US$ Million) Table 14. Global Marine Biopharmaceutical Market Share by Region (2021-2026) Table 15. Global Marine Biopharmaceutical Market Size by Region (2027-2032) & (US$ Million) Table 16. Global Marine Biopharmaceutical Market Share by Region (2027-2032) Table 17. Global Marine Biopharmaceutical Revenue by Players (US$ Million) & (2021-2026) Table 18. Global Marine Biopharmaceutical Revenue Market Share by Players (2021-2026) Table 19. Global Marine Biopharmaceutical Key Players Ranking, 2024 VS 2025 VS 2026 Table 20. Global Marine Biopharmaceutical Key Players Headquarters & Area Served Table 21. Global Marine Biopharmaceutical Players, Product Type & Application Table 22. Global Marine Biopharmaceutical Players Establishment Date Table 23. Global Players Market Concentration Ratio (CR5 and HHI) Table 24. Global Marine Biopharmaceutical by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 25. Global Marine Biopharmaceutical Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Marine Biopharmaceutical Revenue by Type (2021-2026) & (US$ Million) Table 27. Global Marine Biopharmaceutical Revenue by Type (2027-2032) & (US$ Million) Table 28. Global Marine Biopharmaceutical Revenue Market Share by Type (2021-2026) Table 29. Global Marine Biopharmaceutical Revenue Market Share by Type (2027-2032) Table 30. Global Marine Biopharmaceutical Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Marine Biopharmaceutical Revenue by Application (2021-2026) & (US$ Million) Table 32. Global Marine Biopharmaceutical Revenue by Application (2027-2032) & (US$ Million) Table 33. Global Marine Biopharmaceutical Revenue Market Share by Application (2021-2026) Table 34. Global Marine Biopharmaceutical Revenue Market Share by Application (2027-2032) Table 35. Takeda Company Information Table 36. Takeda Business Overview Table 37. Takeda Marine Biopharmaceutical Revenue and Gross Margin (US$ Million) & (2021-2026) Table 38. Takeda Marine Biopharmaceutical Product Portfolio Table 39. Takeda Recent Development Table 40. Pfizer Company Information Table 41. Pfizer Business Overview Table 42. Pfizer Marine Biopharmaceutical Revenue and Gross Margin (US$ Million) & (2021-2026) Table 43. Pfizer Marine Biopharmaceutical Product Portfolio Table 44. Pfizer Recent Development Table 45. GSK Company Information Table 46. GSK Business Overview Table 47. GSK Marine Biopharmaceutical Revenue and Gross Margin (US$ Million) & (2021-2026) Table 48. GSK Marine Biopharmaceutical Product Portfolio Table 49. GSK Recent Development Table 50. TerSera Therapeutics Company Information Table 51. TerSera Therapeutics Business Overview Table 52. TerSera Therapeutics Marine Biopharmaceutical Revenue and Gross Margin (US$ Million) & (2021-2026) Table 53. TerSera Therapeutics Marine Biopharmaceutical Product Portfolio Table 54. TerSera Therapeutics Recent Development Table 55. Seattle Genetics Company Information Table 56. Seattle Genetics Business Overview Table 57. Seattle Genetics Marine Biopharmaceutical Revenue and Gross Margin (US$ Million) & (2021-2026) Table 58. Seattle Genetics Marine Biopharmaceutical Product Portfolio Table 59. Seattle Genetics Recent Development Table 60. Pharma Mar SA Company Information Table 61. Pharma Mar SA Business Overview Table 62. Pharma Mar SA Marine Biopharmaceutical Revenue and Gross Margin (US$ Million) & (2021-2026) Table 63. Pharma Mar SA Marine Biopharmaceutical Product Portfolio Table 64. Pharma Mar SA Recent Development Table 65. Pelagia (EPAX) Company Information Table 66. Pelagia (EPAX) Business Overview Table 67. Pelagia (EPAX) Marine Biopharmaceutical Revenue and Gross Margin (US$ Million) & (2021-2026) Table 68. Pelagia (EPAX) Marine Biopharmaceutical Product Portfolio Table 69. Pelagia (EPAX) Recent Development Table 70. Nordic Naturals Company Information Table 71. Nordic Naturals Business Overview Table 72. Nordic Naturals Marine Biopharmaceutical Revenue and Gross Margin (US$ Million) & (2021-2026) Table 73. Nordic Naturals Marine Biopharmaceutical Product Portfolio Table 74. Nordic Naturals Recent Development Table 75. GNC Company Information Table 76. GNC Business Overview Table 77. GNC Marine Biopharmaceutical Revenue and Gross Margin (US$ Million) & (2021-2026) Table 78. GNC Marine Biopharmaceutical Product Portfolio Table 79. GNC Recent Development Table 80. Eisai Co Company Information Table 81. Eisai Co Business Overview Table 82. Eisai Co Marine Biopharmaceutical Revenue and Gross Margin (US$ Million) & (2021-2026) Table 83. Eisai Co Marine Biopharmaceutical Product Portfolio Table 84. Eisai Co Recent Development Table 85. DSM Company Information Table 86. DSM Business Overview Table 87. DSM Marine Biopharmaceutical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 88. DSM Marine Biopharmaceutical Product Portfolio Table 89. DSM Recent Development Table 90. Croda Company Information Table 91. Croda Business Overview Table 92. Croda Marine Biopharmaceutical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 93. Croda Marine Biopharmaceutical Product Portfolio Table 94. Croda Recent Development Table 95. Carlson Labs Company Information Table 96. Carlson Labs Business Overview Table 97. Carlson Labs Marine Biopharmaceutical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 98. Carlson Labs Marine Biopharmaceutical Product Portfolio Table 99. Carlson Labs Recent Development Table 100. BASF Company Information Table 101. BASF Business Overview Table 102. BASF Marine Biopharmaceutical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 103. BASF Marine Biopharmaceutical Product Portfolio Table 104. BASF Recent Development Table 105. Amway Company Information Table 106. Amway Business Overview Table 107. Amway Marine Biopharmaceutical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 108. Amway Marine Biopharmaceutical Product Portfolio Table 109. Amway Recent Development Table 110. North America Marine Biopharmaceutical Revenue by Type (2021-2026) & (US$ Million) Table 111. North America Marine Biopharmaceutical Revenue by Type (2027-2032) & (US$ Million) Table 112. North America Marine Biopharmaceutical Revenue by Application (2021-2026) & (US$ Million) Table 113. North America Marine Biopharmaceutical Revenue by Application (2027-2032) & (US$ Million) Table 114. North America Marine Biopharmaceutical Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 115. North America Marine Biopharmaceutical Revenue by Country (2021-2026) & (US$ Million) Table 116. North America Marine Biopharmaceutical Revenue by Country (US$ Million) & (2027-2032) Table 117. Europe Marine Biopharmaceutical Revenue by Type (2021-2026) & (US$ Million) Table 118. Europe Marine Biopharmaceutical Revenue by Type (2027-2032) & (US$ Million) Table 119. Europe Marine Biopharmaceutical Revenue by Application (2021-2026) & (US$ Million) Table 120. Europe Marine Biopharmaceutical Revenue by Application (2027-2032) & (US$ Million) Table 121. Europe Marine Biopharmaceutical Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 122. Europe Marine Biopharmaceutical Revenue by Country (2021-2026) & (US$ Million) Table 123. Europe Marine Biopharmaceutical Revenue by Country (US$ Million) & (2027-2032) Table 124. China Marine Biopharmaceutical Revenue by Type (2021-2026) & (US$ Million) Table 125. China Marine Biopharmaceutical Revenue by Type (2027-2032) & (US$ Million) Table 126. China Marine Biopharmaceutical Revenue by Application (2021-2026) & (US$ Million) Table 127. China Marine Biopharmaceutical Revenue by Application (2027-2032) & (US$ Million) Table 128. Asia Marine Biopharmaceutical Revenue by Type (2021-2026) & (US$ Million) Table 129. Asia Marine Biopharmaceutical Revenue by Type (2027-2032) & (US$ Million) Table 130. Asia Marine Biopharmaceutical Revenue by Application (2021-2026) & (US$ Million) Table 131. Asia Marine Biopharmaceutical Revenue by Application (2027-2032) & (US$ Million) Table 132. Asia Marine Biopharmaceutical Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 133. Asia Marine Biopharmaceutical Revenue by Region (US$ Million) & (2021-2026) Table 134. Asia Marine Biopharmaceutical Revenue by Region (US$ Million) & (2027-2032) Table 135. SAMEA Marine Biopharmaceutical Revenue by Type (2021-2026) & (US$ Million) Table 136. SAMEA Marine Biopharmaceutical Revenue by Type (2027-2032) & (US$ Million) Table 137. SAMEA Marine Biopharmaceutical Revenue by Application (2021-2026) & (US$ Million) Table 138. SAMEA Marine Biopharmaceutical Revenue by Application (2027-2032) & (US$ Million) Table 139. SAMEA Marine Biopharmaceutical Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 140. SAMEA Marine Biopharmaceutical Revenue by Country (2021-2026) & (US$ Million) Table 141. SAMEA Marine Biopharmaceutical Revenue by Country (US$ Million) & (2027-2032) Table 142. Research Programs/Design for This Report Table 143. Authors List of This Report Table 144. Secondary Sources Table 145. Primary Sources List of Figures Figure 1. Marine Biopharmaceutical Image Figure 2. Global Marine Biopharmaceutical Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Marine Biopharmaceutical Market Size Share 2021 VS 2025 VS 2032 Figure 4. Drugs Image Figure 5. Health Supplement Image Figure 6. Global Marine Biopharmaceutical Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Marine Biopharmaceutical Market Size Share 2021 VS 2025 VS 2032 Figure 8. Hospital & Clinic Image Figure 9. Pharmacy Image Figure 10. Other Image Figure 11. Global Marine Biopharmaceutical Market Size (US$ Million) & (2021-2032) Figure 12. Global Marine Biopharmaceutical Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Marine Biopharmaceutical Market Share by Region: 2021 VS 2025 VS 2032 Figure 14. Global Marine Biopharmaceutical Players Revenue Share Top 10 and Top 5 in 2025 Figure 15. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 16. Global Marine Biopharmaceutical Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Marine Biopharmaceutical Revenue Market Share 2021 VS 2025 VS 2032 Figure 18. Global Marine Biopharmaceutical Revenue Market Share by Type (2021-2032) Figure 19. Global Marine Biopharmaceutical Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Marine Biopharmaceutical Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 21. Global Marine Biopharmaceutical Revenue Market Share by Application (2021-2032) Figure 22. North America Marine Biopharmaceutical Revenue YoY Growth (2021-2032) & (US$ Million) Figure 23. North America Marine Biopharmaceutical Revenue Share by Type (2021-2032) Figure 24. North America Marine Biopharmaceutical Revenue Share by Application (2021-2032) Figure 25. North America Marine Biopharmaceutical Revenue Share by Country (2021-2032) Figure 26. United States Marine Biopharmaceutical Revenue YoY Growth (US$ Million) & (2021-2032) Figure 27. Canada Marine Biopharmaceutical Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Mexico Marine Biopharmaceutical Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Europe Marine Biopharmaceutical Revenue YoY Growth (2021-2032) & (US$ Million) Figure 30. Europe Marine Biopharmaceutical Revenue Share by Type (2021-2032) Figure 31. Europe Marine Biopharmaceutical Revenue Share by Application (2021-2032) Figure 32. Europe Marine Biopharmaceutical Revenue Share by Country (2021-2032) Figure 33. Germany Marine Biopharmaceutical Revenue YoY Growth (US$ Million) & (2021-2032) Figure 34. France Marine Biopharmaceutical Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. U.K. Marine Biopharmaceutical Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. Italy Marine Biopharmaceutical Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Spain Marine Biopharmaceutical Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Russia Marine Biopharmaceutical Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Netherlands Marine Biopharmaceutical Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Nordic Countries Marine Biopharmaceutical Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. China Marine Biopharmaceutical Revenue YoY Growth (2021-2032) & (US$ Million) Figure 42. China Marine Biopharmaceutical Revenue Share by Type (2021-2032) Figure 43. China Marine Biopharmaceutical Revenue Share by Application (2021-2032) Figure 44. Asia Marine Biopharmaceutical Revenue YoY Growth (2021-2032) & (US$ Million) Figure 45. Asia Marine Biopharmaceutical Revenue Share by Type (2021-2032) Figure 46. Asia Marine Biopharmaceutical Revenue Share by Application (2021-2032) Figure 47. Asia Marine Biopharmaceutical Revenue Share by Region (2021-2032) Figure 48. Japan Marine Biopharmaceutical Revenue YoY Growth (US$ Million) & (2021-2032) Figure 49. South Korea Marine Biopharmaceutical Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. India Marine Biopharmaceutical Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. Australia Marine Biopharmaceutical Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Taiwan Marine Biopharmaceutical Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Southeast Asia Marine Biopharmaceutical Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. SAMEA Marine Biopharmaceutical Revenue YoY Growth (2021-2032) & (US$ Million) Figure 55. SAMEA Marine Biopharmaceutical Revenue Share by Type (2021-2032) Figure 56. SAMEA Marine Biopharmaceutical Revenue Share by Application (2021-2032) Figure 57. SAMEA Marine Biopharmaceutical Revenue Share by Country (2021-2032) Figure 58. Brazil Marine Biopharmaceutical Revenue YoY Growth (US$ Million) & (2021-2032) Figure 59. Argentina Marine Biopharmaceutical Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Chile Marine Biopharmaceutical Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Colombia Marine Biopharmaceutical Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Peru Marine Biopharmaceutical Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Saudi Arabia Marine Biopharmaceutical Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Israel Marine Biopharmaceutical Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. UAE Marine Biopharmaceutical Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Turkey Marine Biopharmaceutical Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Iran Marine Biopharmaceutical Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Egypt Marine Biopharmaceutical Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Drugs
  • Health Supplement
Applications
  • Hospital & Clinic
  • Pharmacy
  • Other
Companies covered
  • Takeda
  • Pfizer
  • GSK
  • TerSera Therapeutics
  • Seattle Genetics
  • Pharma Mar SA
  • Pelagia (EPAX)
  • Nordic Naturals
  • GNC
  • Eisai Co
  • DSM
  • Croda
  • Carlson Labs
  • BASF
  • Amway

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Marine Biopharmaceutical Market by Type
  3. 1.2.1 Global Marine Biopharmaceutical Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Drugs
  5. 1.2.3 Health Supplement
  6. 1.3 Marine Biopharmaceutical Market by Application
  7. 1.3.1 Global Marine Biopharmaceutical Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Hospital & Clinic
  9. 1.3.3 Pharmacy
  10. 1.3.4 Other
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Marine Biopharmaceutical Market Dynamics
  1. 2.1 Marine Biopharmaceutical Industry Trends
  2. 2.2 Marine Biopharmaceutical Industry Drivers
  3. 2.3 Marine Biopharmaceutical Industry Opportunities and Challenges
  4. 2.4 Marine Biopharmaceutical Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Marine Biopharmaceutical Market Perspective (2021-2032)
  2. 3.2 Global Marine Biopharmaceutical Growth Trends by Region
  3. 3.2.1 Global Marine Biopharmaceutical Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Marine Biopharmaceutical Market Size by Region (2021-2026)
  5. 3.2.3 Global Marine Biopharmaceutical Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Marine Biopharmaceutical Revenue by Players
  2. 4.1.1 Global Marine Biopharmaceutical Revenue by Players (2021-2026)
  3. 4.1.2 Global Marine Biopharmaceutical Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Marine Biopharmaceutical Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Marine Biopharmaceutical Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Marine Biopharmaceutical Key Players Headquarters & Area Served
  7. 4.4 Global Marine Biopharmaceutical Players, Product Type & Application
  8. 4.5 Global Marine Biopharmaceutical Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Marine Biopharmaceutical Market CR5 and HHI
  11. 4.6.3 2025 Marine Biopharmaceutical Tier 1, Tier 2, and Tier 3
5 Marine Biopharmaceutical Market Size by Type
  1. 5.1 Global Marine Biopharmaceutical Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Marine Biopharmaceutical Revenue by Type (2021-2032)
  3. 5.3 Global Marine Biopharmaceutical Revenue Market Share by Type (2021-2032)
6 Marine Biopharmaceutical Market Size by Application
  1. 6.1 Global Marine Biopharmaceutical Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Marine Biopharmaceutical Revenue by Application (2021-2032)
  3. 6.3 Global Marine Biopharmaceutical Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Takeda
  2. 7.1.1 Takeda Company Information
  3. 7.1.2 Takeda Business Overview
  4. 7.1.3 Takeda Marine Biopharmaceutical Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Takeda Marine Biopharmaceutical Product Portfolio
  6. 7.1.5 Takeda Recent Developments
  7. 7.2 Pfizer
  8. 7.2.1 Pfizer Company Information
  9. 7.2.2 Pfizer Business Overview
  10. 7.2.3 Pfizer Marine Biopharmaceutical Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Pfizer Marine Biopharmaceutical Product Portfolio
  12. 7.2.5 Pfizer Recent Developments
  13. 7.3 GSK
  14. 7.3.1 GSK Company Information
  15. 7.3.2 GSK Business Overview
  16. 7.3.3 GSK Marine Biopharmaceutical Revenue and Gross Margin (2021-2026)
  17. 7.3.4 GSK Marine Biopharmaceutical Product Portfolio
  18. 7.3.5 GSK Recent Developments
  19. 7.4 TerSera Therapeutics
  20. 7.4.1 TerSera Therapeutics Company Information
  21. 7.4.2 TerSera Therapeutics Business Overview
  22. 7.4.3 TerSera Therapeutics Marine Biopharmaceutical Revenue and Gross Margin (2021-2026)
  23. 7.4.4 TerSera Therapeutics Marine Biopharmaceutical Product Portfolio
  24. 7.4.5 TerSera Therapeutics Recent Developments
  25. 7.5 Seattle Genetics
  26. 7.5.1 Seattle Genetics Company Information
  27. 7.5.2 Seattle Genetics Business Overview
  28. 7.5.3 Seattle Genetics Marine Biopharmaceutical Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Seattle Genetics Marine Biopharmaceutical Product Portfolio
  30. 7.5.5 Seattle Genetics Recent Developments
  31. 7.6 Pharma Mar SA
  32. 7.6.1 Pharma Mar SA Company Information
  33. 7.6.2 Pharma Mar SA Business Overview
  34. 7.6.3 Pharma Mar SA Marine Biopharmaceutical Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Pharma Mar SA Marine Biopharmaceutical Product Portfolio
  36. 7.6.5 Pharma Mar SA Recent Developments
  37. 7.7 Pelagia (EPAX)
  38. 7.7.1 Pelagia (EPAX) Company Information
  39. 7.7.2 Pelagia (EPAX) Business Overview
  40. 7.7.3 Pelagia (EPAX) Marine Biopharmaceutical Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Pelagia (EPAX) Marine Biopharmaceutical Product Portfolio
  42. 7.7.5 Pelagia (EPAX) Recent Developments
  43. 7.8 Nordic Naturals
  44. 7.8.1 Nordic Naturals Company Information
  45. 7.8.2 Nordic Naturals Business Overview
  46. 7.8.3 Nordic Naturals Marine Biopharmaceutical Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Nordic Naturals Marine Biopharmaceutical Product Portfolio
  48. 7.8.5 Nordic Naturals Recent Developments
  49. 7.9 GNC
  50. 7.9.1 GNC Company Information
  51. 7.9.2 GNC Business Overview
  52. 7.9.3 GNC Marine Biopharmaceutical Revenue and Gross Margin (2021-2026)
  53. 7.9.4 GNC Marine Biopharmaceutical Product Portfolio
  54. 7.9.5 GNC Recent Developments
  55. 7.10 Eisai Co
  56. 7.10.1 Eisai Co Company Information
  57. 7.10.2 Eisai Co Business Overview
  58. 7.10.3 Eisai Co Marine Biopharmaceutical Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Eisai Co Marine Biopharmaceutical Product Portfolio
  60. 7.10.5 Eisai Co Recent Developments
  61. 7.11 DSM
  62. 7.11.1 DSM Company Information
  63. 7.11.2 DSM Business Overview
  64. 7.11.3 DSM Marine Biopharmaceutical Revenue and Gross Margin (2021-2026)
  65. 7.11.4 DSM Marine Biopharmaceutical Product Portfolio
  66. 7.11.5 DSM Recent Developments
  67. 7.12 Croda
  68. 7.12.1 Croda Company Information
  69. 7.12.2 Croda Business Overview
  70. 7.12.3 Croda Marine Biopharmaceutical Revenue and Gross Margin (2021-2026)
  71. 7.12.4 Croda Marine Biopharmaceutical Product Portfolio
  72. 7.12.5 Croda Recent Developments
  73. 7.13 Carlson Labs
  74. 7.13.1 Carlson Labs Company Information
  75. 7.13.2 Carlson Labs Business Overview
  76. 7.13.3 Carlson Labs Marine Biopharmaceutical Revenue and Gross Margin (2021-2026)
  77. 7.13.4 Carlson Labs Marine Biopharmaceutical Product Portfolio
  78. 7.13.5 Carlson Labs Recent Developments
  79. 7.14 BASF
  80. 7.14.1 BASF Company Information
  81. 7.14.2 BASF Business Overview
  82. 7.14.3 BASF Marine Biopharmaceutical Revenue and Gross Margin (2021-2026)
  83. 7.14.4 BASF Marine Biopharmaceutical Product Portfolio
  84. 7.14.5 BASF Recent Developments
  85. 7.15 Amway
  86. 7.15.1 Amway Company Information
  87. 7.15.2 Amway Business Overview
  88. 7.15.3 Amway Marine Biopharmaceutical Revenue and Gross Margin (2021-2026)
  89. 7.15.4 Amway Marine Biopharmaceutical Product Portfolio
  90. 7.15.5 Amway Recent Developments
8 North America
  1. 8.1 North America Marine Biopharmaceutical Revenue (2021-2032)
  2. 8.2 North America Marine Biopharmaceutical Revenue by Type (2021-2032)
  3. 8.2.1 North America Marine Biopharmaceutical Revenue by Type (2021-2026)
  4. 8.2.2 North America Marine Biopharmaceutical Revenue by Type (2027-2032)
  5. 8.3 North America Marine Biopharmaceutical Revenue Share by Type (2021-2032)
  6. 8.4 North America Marine Biopharmaceutical Revenue by Application (2021-2032)
  7. 8.4.1 North America Marine Biopharmaceutical Revenue by Application (2021-2026)
  8. 8.4.2 North America Marine Biopharmaceutical Revenue by Application (2027-2032)
  9. 8.5 North America Marine Biopharmaceutical Revenue Share by Application (2021-2032)
  10. 8.6 North America Marine Biopharmaceutical Revenue by Country
  11. 8.6.1 North America Marine Biopharmaceutical Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Marine Biopharmaceutical Revenue by Country (2021-2026)
  13. 8.6.3 North America Marine Biopharmaceutical Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
9 Europe
  1. 9.1 Europe Marine Biopharmaceutical Revenue (2021-2032)
  2. 9.2 Europe Marine Biopharmaceutical Revenue by Type (2021-2032)
  3. 9.2.1 Europe Marine Biopharmaceutical Revenue by Type (2021-2026)
  4. 9.2.2 Europe Marine Biopharmaceutical Revenue by Type (2027-2032)
  5. 9.3 Europe Marine Biopharmaceutical Revenue Share by Type (2021-2032)
  6. 9.4 Europe Marine Biopharmaceutical Revenue by Application (2021-2032)
  7. 9.4.1 Europe Marine Biopharmaceutical Revenue by Application (2021-2026)
  8. 9.4.2 Europe Marine Biopharmaceutical Revenue by Application (2027-2032)
  9. 9.5 Europe Marine Biopharmaceutical Revenue Share by Application (2021-2032)
  10. 9.6 Europe Marine Biopharmaceutical Revenue by Country
  11. 9.6.1 Europe Marine Biopharmaceutical Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Marine Biopharmaceutical Revenue by Country (2021-2026)
  13. 9.6.3 Europe Marine Biopharmaceutical Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Netherlands
10 China
  1. 10.1 China Marine Biopharmaceutical Revenue (2021-2032)
  2. 10.2 China Marine Biopharmaceutical Revenue by Type (2021-2032)
  3. 10.2.1 China Marine Biopharmaceutical Revenue by Type (2021-2026)
  4. 10.2.2 China Marine Biopharmaceutical Revenue by Type (2027-2032)
  5. 10.3 China Marine Biopharmaceutical Revenue Share by Type (2021-2032)
  6. 10.4 China Marine Biopharmaceutical Revenue by Application (2021-2032)
  7. 10.4.1 China Marine Biopharmaceutical Revenue by Application (2021-2026)
  8. 10.4.2 China Marine Biopharmaceutical Revenue by Application (2027-2032)
  9. 10.5 China Marine Biopharmaceutical Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Marine Biopharmaceutical Revenue (2021-2032)
  2. 11.2 Asia Marine Biopharmaceutical Revenue by Type (2021-2032)
  3. 11.2.1 Asia Marine Biopharmaceutical Revenue by Type (2021-2026)
  4. 11.2.2 Asia Marine Biopharmaceutical Revenue by Type (2027-2032)
  5. 11.3 Asia Marine Biopharmaceutical Revenue Share by Type (2021-2032)
  6. 11.4 Asia Marine Biopharmaceutical Revenue by Application (2021-2032)
  7. 11.4.1 Asia Marine Biopharmaceutical Revenue by Application (2021-2026)
  8. 11.4.2 Asia Marine Biopharmaceutical Revenue by Application (2027-2032)
  9. 11.5 Asia Marine Biopharmaceutical Revenue Share by Application (2021-2032)
  10. 11.6 Asia Marine Biopharmaceutical Revenue by Country
  11. 11.6.1 Asia Marine Biopharmaceutical Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Marine Biopharmaceutical Revenue by Country (2021-2026)
  13. 11.6.3 Asia Marine Biopharmaceutical Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Marine Biopharmaceutical Revenue (2021-2032)
  2. 12.2 SAMEA Marine Biopharmaceutical Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Marine Biopharmaceutical Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Marine Biopharmaceutical Revenue by Type (2027-2032)
  5. 12.3 SAMEA Marine Biopharmaceutical Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Marine Biopharmaceutical Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Marine Biopharmaceutical Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Marine Biopharmaceutical Revenue by Application (2027-2032)
  9. 12.5 SAMEA Marine Biopharmaceutical Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Marine Biopharmaceutical Revenue by Country
  11. 12.6.1 SAMEA Marine Biopharmaceutical Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Marine Biopharmaceutical Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Marine Biopharmaceutical Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst